跳至主要内容
临床试验/CTRI/2021/01/030660
CTRI/2021/01/030660尚未招募1 期

A clinicopathological study on Prameha Purvarupa (Pre-Diabetic Condition) and its management with Nisha-Amalaki Churna and Shilajeet Vati - NACSV

Esha Dhiman0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Both new and treated cases will be included.
  • 2. Patients who fulfill the diagnostic criteria.
  • 3. Patients age between 30-65 years.
  • 4. Patients having fasting plasma glucose 100-
  • 5. Patients having oral glucose tolerance 140-
  • 6. Patients with HbA1c 5.7%-6.4%
  • 7. Patients having symptoms of Prabhuta mutrata
  • (frequency of micturition), pipasa (increased
  • thirst), kshudha (excessive appetite), kara-
  • pada daha (burning sensation in hand and
  • feet), kara-pada suptata (numbness of hand
  • and feet), sweda pravritti (excessive
  • sweating), mukha shosha (dry mouth), mukha
  • madhurya (sweetness in mouth), sheeta priyata
  • (liking for cold things) madhura shukla
  • mutrata (sweetness in urine).
  • 8. Subject willing to follow the procedures as
  • per the study protocol and voluntarily
  • signing informed consent form.

排除标准

  • 1. Patients age <30 years and >65 years .
  • 2. Patients having fasting plasma glucose >
  • 3. Patients having oral glucose tolerance >
  • 4. Patients with HbA1c 6.5% or more.
  • 5. Patients having complications of diabetes
  • like ketoacidosis, nephropathy, neuropathy,
  • retinopathy, and diabetic wounds.
  • 6. Patients having chronic, contagious infection
  • disease such as active tuberculosis, hepatits
  • B or C, or HIV
  • 7. Pregnant and lactating females.
  • 8. Patients having active metabolic or
  • gastrointestinal disease that may interfere
  • with nutrient absorption, metabolism,
  • excretion, excluding diabetes.
  • 9. Type-1 diabetes mellitus and Type-2 diabetes
  • 10. Any other patient considered not fit for

研究者

发起方
Esha Dhiman

相似试验